SKI Market

A+| A| A-|

Indian Indices

Sensex

77,569.39 827.57
( 1.08%)

Global Indices

Nasdaq

52,499.17 129.78
(0.25%)

Dow Jones

7,562.80 59.09
(0.79%)

Hang Seng

68,634.11 890.26
(1.31%)

Nikkei 225

10,472.08 -16.96
(-0.16%)

Forex

USD-INR

95.15 -0.21
(-0.22%)

EUR-INR

108.73 -0.26
(-0.24%)

GBP-INR

127.27 -0.11
(-0.09%)

JPY-INR

0.59 0.00
(-0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

338.0498657

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

43.86

41293.72

EPS(TTM)

Face Value()

Div & Yield %

75.36

0.85

Back

ludlow jute & specialities ltd

Man Infraconstruction consolidated net profit declines 43.92% in the December 2025 quarter

Feb 11,2026

Net profit of Man Infraconstruction declined 43.92% to Rs 46.97 crore in the quarter ended December 2025 as against Rs 83.76 crore during the previous quarter ended December 2024. Sales declined 36.74% to Rs 153.30 crore in the quarter ended December 2025 as against Rs 242.33 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	153.30	242.33	-37
OPM %	21.37	25.13	-
PBDT	75.64	91.01	-17
PBT	72.12	88.91	-19
NP	46.97	83.76	-44

77,569.39 827.57 ( 1.08%)

52,499.17 129.78 (0.25%)

7,562.80 59.09 (0.79%)

68,634.11 890.26 (1.31%)

10,472.08 -16.96 (-0.16%)

95.15 -0.21 (-0.22%)

108.73 -0.26 (-0.24%)

127.27 -0.11 (-0.09%)

0.59 0.00 (-0.14%)